OTCMKTS:FSNUY - FRESENIUS SE &/S Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $13.1150 -0.72 (-5.20 %) (As of 03/22/2019 04:00 PM ET)Previous Close$13.1150Today's Range$13.06 - $13.2252-Week Range$11.00 - $20.64Volume8,647 shsAverage Volume17,426 shsMarket Capitalization$29.18 billionP/E Ratio14.26Dividend Yield1.06%Beta1.27 ProfileDiscussionAnalyst RatingsChartDividendEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis- related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs, including intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing of blood components, as well as in transfusion medicine. The Fresenius Helios segment operates 111 hospitals with approximately 35,000 beds, such as 88 acute care hospitals and 23 post-acute care clinics; 4 post-acute care centers; 17 prevention centers; and 12 nursing homes. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany. Receive FSNUY News and Ratings via Email Sign-up to receive the latest news and ratings for FSNUY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:FSNUY Previous Symbol CUSIPN/A CIKN/A Webwww.fresenius.com Phone49-6172-6080Debt Debt-to-Equity Ratio1.04 Current Ratio1.18 Quick Ratio0.92Price-To-Earnings Trailing P/E Ratio14.26 Forward P/E Ratio13.25 P/E Growth2.08 Sales & Book Value Annual Sales$38.28 billion Price / Sales0.76 Cash Flow$1.5707 per share Price / Cash Flow8.35 Book Value$11.07 per share Price / Book1.18Profitability EPS (Most Recent Fiscal Year)$0.92 Net Income$2.05 billion Net Margins5.91% Return on Equity12.53% Return on Assets3.85%Miscellaneous Employees273,249 Outstanding Shares2,224,910,000Market Cap$29.18 billion Next Earnings Date3/25/2019 (Estimated) OptionableNot Optionable FRESENIUS SE &/S (OTCMKTS:FSNUY) Frequently Asked Questions What is FRESENIUS SE &/S's stock symbol? FRESENIUS SE &/S trades on the OTCMKTS under the ticker symbol "FSNUY." When is FRESENIUS SE &/S's next earnings date? FRESENIUS SE &/S is scheduled to release their next quarterly earnings announcement on Monday, March 25th 2019. View Earnings Estimates for FRESENIUS SE &/S. What is the consensus analysts' recommendation for FRESENIUS SE &/S? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for FRESENIUS SE &/S in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for FRESENIUS SE &/S. Has FRESENIUS SE &/S been receiving favorable news coverage? Media stories about FSNUY stock have been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. FRESENIUS SE &/S earned a coverage optimism score of 0.6 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. Who are some of FRESENIUS SE &/S's key competitors? Some companies that are related to FRESENIUS SE &/S include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), DexCom (DXCM), Hill-Rom (HRC), Insulet (PODD), Penumbra (PEN), Integra Lifesciences (IART), ICU Medical (ICUI) and Globus Medical (GMED). What other stocks do shareholders of FRESENIUS SE &/S own? Based on aggregate information from My MarketBeat watchlists, some companies that other FRESENIUS SE &/S investors own include IBM (IBM), Synergy Pharmaceuticals (SGYP), Alibaba Group (BABA), Huron Consulting Group (HURN), Toll Brothers (TOL), Booking (BKNG), Roche Holdings AG Basel (RHHBY), Progressive (PGR), Samsung Electronics (SSNLF) and Qorvo (QRVO). Who are FRESENIUS SE &/S's key executives? FRESENIUS SE &/S's management team includes the folowing people: Mr. Stephan Sturm, CEO & Chairman of Management Board - Fresenius Management SE (Age 56)Ms. Rachel Clare Empey, CFO & Member of Management Board - Fresenius Management SE (Age 43)Dr. Francesco De Meo, Member of Management Board - Fresenius Management SE (Age 55)Dr. Jürgen Götz, Chief Legal & Compliance Officer & Labor Relations Director and Member of Management Board - GP (Age 55)Dr. Ernst Wastler, Member of Management Board - Fresenius Management SE (Age 60) How do I buy shares of FRESENIUS SE &/S? Shares of FSNUY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is FRESENIUS SE &/S's stock price today? One share of FSNUY stock can currently be purchased for approximately $13.1150. How big of a company is FRESENIUS SE &/S? FRESENIUS SE &/S has a market capitalization of $29.18 billion and generates $38.28 billion in revenue each year. The company earns $2.05 billion in net income (profit) each year or $0.92 on an earnings per share basis. FRESENIUS SE &/S employs 273,249 workers across the globe. What is FRESENIUS SE &/S's official website? The official website for FRESENIUS SE &/S is http://www.fresenius.com. How can I contact FRESENIUS SE &/S? FRESENIUS SE &/S's mailing address is Else-Kroner-Stra¿e 1, Bad Homburg 2M, 61352. The company can be reached via phone at 49-6172-6080 or via email at [email protected] MarketBeat Community Rating for FRESENIUS SE &/S (OTCMKTS FSNUY)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 128 (Vote Outperform)Underperform Votes: 150 (Vote Underperform)Total Votes: 278MarketBeat's community ratings are surveys of what our community members think about FRESENIUS SE &/S and other stocks. Vote "Outperform" if you believe FSNUY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FSNUY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/23/2019 by MarketBeat.com StaffFeatured Article: Is the QQQ ETF safe?